Bausch Health Companies Inc
TSX:BHC

Watchlist Manager
Bausch Health Companies Inc Logo
Bausch Health Companies Inc
TSX:BHC
Watchlist
Price: 11.38 CAD 2.52%
Market Cap: 4.2B CAD
Have any thoughts about
Bausch Health Companies Inc?
Write Note

Bausch Health Companies Inc
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bausch Health Companies Inc
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Bausch Health Companies Inc
TSX:BHC
Other Long-Term Assets
$2.6B
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
26%
Sundial Growers Inc
NASDAQ:SNDL
Other Long-Term Assets
CA$4.8m
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Other Long-Term Assets
$41k
CAGR 3-Years
-57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Other Long-Term Assets
$493k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Other Long-Term Assets
CA$28.6m
CAGR 3-Years
41%
CAGR 5-Years
86%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Other Long-Term Assets
$12.9m
CAGR 3-Years
-60%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Bausch Health Companies Inc
Glance View

Market Cap
4.2B CAD
Industry
Pharmaceuticals

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. The company is headquartered in Laval, Quebec and currently employs 19,600 full-time employees. The firm is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices), which are marketed directly or indirectly in over 100 countries. Its segments include Bausch + Lomb, Salix, Ortho Dermatologics, International Rx and Diversified Products. The Bausch + Lomb segment consists of sales in the United States of Bausch + Lomb Vision Care, Consumer, Surgical and Ophthalmology Rx products. The Salix segment consists of sales in the United States of gastroenterology (GI) products. The Ortho Dermatologics segment consists of sales in the United States of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices.

BHC Intrinsic Value
114.17 CAD
Undervaluation 90%
Intrinsic Value
Price

See Also

What is Bausch Health Companies Inc's Other Long-Term Assets?
Other Long-Term Assets
2.6B USD

Based on the financial report for Sep 30, 2024, Bausch Health Companies Inc's Other Long-Term Assets amounts to 2.6B USD.

What is Bausch Health Companies Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
26%

Over the last year, the Other Long-Term Assets growth was 2%.

Back to Top